<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmexec.findpharma.com/pharmexec/servlet/pharmexec_48282.rss?id=48282">
    <title>Pharmaceutical Executive - Europe News</title>

    <link>http://pharmexec.findpharma.com/pharmexec/Europe+News/Article/list/48282</link>

    <description>European news</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Bio-Entrepreneur-School-Welcomes-New-Applications/ArticleStandard/Article/detail/641866?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Novo-Nordisk-Reports-30-Increased-Operating-Profit/ArticleStandard/Article/detail/638252?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/10000-UK-Cancer-Deaths-Could-be-Avoided/ArticleStandard/Article/detail/637078?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/CROs-United/ArticleStandard/Article/detail/636759?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/UKs-NICE-Rejects-GSK-Breast-Cancer-Treatment/ArticleStandard/Article/detail/635531?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Switzerlands-Medicines-for-Malaria-Receives-Gates-/ArticleStandard/Article/detail/634872?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Economist-Award-for-Bioscience-Announced/ArticleStandard/Article/detail/633542?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/RA-Treatment-Uneven-Across-Europe/ArticleStandard/Article/detail/633347?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Sandoz-Launches-First-Biosimilar-in-Japan/ArticleStandard/Article/detail/631745?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Takeda-Targets-Most-Promising-Markets/ArticleStandard/Article/detail/631226?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Biotech-Uneven-in-EU-Member-States/ArticleStandard/Article/detail/631115?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Sanofi-Acquires-Fovea-in-370M-Deal/ArticleStandard/Article/detail/630595?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Almac-Plans-500-New-Jobs-for-Northern-Ireland/ArticleStandard/Article/detail/630142?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Helsinn-and-Eisai-Italy-in-licensing-agreement/ArticleStandard/Article/detail/626804?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/IMI-Announces-Next-Topics-for-Research/ArticleStandard/Article/detail/626551?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/AstraZeneca-wins-over-UK-doctors/ArticleStandard/Article/detail/625465?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Algeta-amp-Bayer-in-cancer-drug-deal/ArticleStandard/Article/detail/623829?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Global-Cancer-Cases-to-Grow-by-30-Per-Cent/ArticleStandard/Article/detail/623601?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Guiding-Your-Drug-Name-to-Approval/ArticleStandard/Article/detail/617169?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Pfizer-to-develop-clinical-trial-website/ArticleStandard/Article/detail/620739?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Obama-Advisor-to-Open-Swedish-Life-Sciences-Summit/ArticleStandard/Article/detail/619614?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Is-Tamiflu-Suitable-for-Young-Children/ArticleStandard/Article/detail/617908?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-settles-Nigerian-Trovan-case/ArticleStandard/Article/detail/615966?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/A-busy-time-for-Sanofi/ArticleStandard/Article/detail/615488?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Flu-Vaccines-Fast-Tracked-in-EU/ArticleStandard/Article/detail/615230?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/European-Approval-for-Pfizer-Wyeth-Deal/ArticleStandard/Article/detail/612293?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/UK-Life-Sciences-Blueprint-Welcomed/ArticleStandard/Article/detail/611708?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Servier-Singled-Out-for-New-EU-Antitrust-Investiga/ArticleStandard/Article/detail/609542?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Merck-signs-discovery-deal-with-Xenon/ArticleStandard/Article/detail/603134?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/A-Cautionary-Tale-for-Executives/ArticleStandard/Article/detail/602420?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-completes-European-debt-offering/ArticleStandard/Article/detail/601617?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Pharmaceutical-Execs-Embrace-the-Web/ArticleStandard/Article/detail/601618?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/IMS-revises-predicted-global-pharma-growth-rate/ArticleStandard/Article/detail/601641?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/AstraZeneca-and-Merck-form-collaboration/ArticleStandard/Article/detail/600890?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe/Elan-in-talks-to-sell-stake-to-Bristol/ArticleStandard/Article/detail/600889?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Novartis-buys-Ebewe-injectables-unit/ArticleStandard/Article/detail/600051?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/GSK-to-donate-50-million-pandemic-vaccines/ArticleStandard/Article/detail/600050?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/Ranbaxy-chief-steps-down/ArticleStandard/Article/detail/600047?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/GW-Pharma-seeks-approval-for-cannabis-based-drug/ArticleStandard/Article/detail/600049?contextCategoryId=48282&amp;ref=25" />

        <rdf:li
        resource="http://pharmexec.findpharma.com/pharmexec/Europe+News/UK-charity-plugs-drug-RampD-gap/ArticleStandard/Article/detail/600052?contextCategoryId=48282&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-21T06:48:56Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Bio-Entrepreneur-School-Welcomes-New-Applications/ArticleStandard/Article/detail/641866?contextCategoryId=48282&amp;ref=25">

    <title>Bio-Entrepreneur School Welcomes New Applications</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Bio-Entrepreneur-School-Welcomes-New-Applications/ArticleStandard/Article/detail/641866?contextCategoryId=48282&amp;ref=25</link>

    <description>16 November 2009.</description>

    <dc:date>2009-11-16T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/472009/641866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Novo-Nordisk-Reports-30-Increased-Operating-Profit/ArticleStandard/Article/detail/638252?contextCategoryId=48282&amp;ref=25">

    <title>Novo Nordisk Reports 30% Increased Operating Profit</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Novo-Nordisk-Reports-30-Increased-Operating-Profit/ArticleStandard/Article/detail/638252?contextCategoryId=48282&amp;ref=25</link>

    <description>02 November</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/452009/638252null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/10000-UK-Cancer-Deaths-Could-be-Avoided/ArticleStandard/Article/detail/637078?contextCategoryId=48282&amp;ref=25">

    <title>10,000 UK Cancer Deaths Could be Avoided</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/10000-UK-Cancer-Deaths-Could-be-Avoided/ArticleStandard/Article/detail/637078?contextCategoryId=48282&amp;ref=25</link>

    <description>28 October</description>

    <dc:date>2009-10-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/637078null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/CROs-United/ArticleStandard/Article/detail/636759?contextCategoryId=48282&amp;ref=25">

    <title>CROs United</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/CROs-United/ArticleStandard/Article/detail/636759?contextCategoryId=48282&amp;ref=25</link>

    <description>US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help
    companies get products to market faster by establishing an international network of CROs.</description>

    <dc:date>2009-10-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/636759null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/UKs-NICE-Rejects-GSK-Breast-Cancer-Treatment/ArticleStandard/Article/detail/635531?contextCategoryId=48282&amp;ref=25">

    <title>UK's NICE Rejects GSK Breast Cancer Treatment</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/UKs-NICE-Rejects-GSK-Breast-Cancer-Treatment/ArticleStandard/Article/detail/635531?contextCategoryId=48282&amp;ref=25</link>

    <description>21 October</description>

    <dc:date>2009-10-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635531null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Switzerlands-Medicines-for-Malaria-Receives-Gates-/ArticleStandard/Article/detail/634872?contextCategoryId=48282&amp;ref=25">

    <title>Switzerland's Medicines for Malaria Receives Gates Foundation Award</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Switzerlands-Medicines-for-Malaria-Receives-Gates-/ArticleStandard/Article/detail/634872?contextCategoryId=48282&amp;ref=25</link>

    <description>19 October</description>

    <dc:date>2009-10-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/634872null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Economist-Award-for-Bioscience-Announced/ArticleStandard/Article/detail/633542?contextCategoryId=48282&amp;ref=25">

    <title>Economist Award for Bioscience Innovation Announced</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Economist-Award-for-Bioscience-Announced/ArticleStandard/Article/detail/633542?contextCategoryId=48282&amp;ref=25</link>

    <description>13 October</description>

    <dc:date>2009-10-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/633542null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/RA-Treatment-Uneven-Across-Europe/ArticleStandard/Article/detail/633347?contextCategoryId=48282&amp;ref=25">

    <title>RA Treatment Uneven Across Europe</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/RA-Treatment-Uneven-Across-Europe/ArticleStandard/Article/detail/633347?contextCategoryId=48282&amp;ref=25</link>

    <description>12 October</description>

    <dc:date>2009-10-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/633347null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Sandoz-Launches-First-Biosimilar-in-Japan/ArticleStandard/Article/detail/631745?contextCategoryId=48282&amp;ref=25">

    <title>Sandoz Launches First Biosimilar in Japan</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Sandoz-Launches-First-Biosimilar-in-Japan/ArticleStandard/Article/detail/631745?contextCategoryId=48282&amp;ref=25</link>

    <description>06 October</description>

    <dc:date>2009-10-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631745null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Takeda-Targets-Most-Promising-Markets/ArticleStandard/Article/detail/631226?contextCategoryId=48282&amp;ref=25">

    <title>Takeda Targets Most Promising Markets</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Takeda-Targets-Most-Promising-Markets/ArticleStandard/Article/detail/631226?contextCategoryId=48282&amp;ref=25</link>

    <description>05 October</description>

    <dc:date>2009-10-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631226null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Biotech-Uneven-in-EU-Member-States/ArticleStandard/Article/detail/631115?contextCategoryId=48282&amp;ref=25">

    <title>Biotech &amp;#34;Uneven&amp;#34; in New EU Member States</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Biotech-Uneven-in-EU-Member-States/ArticleStandard/Article/detail/631115?contextCategoryId=48282&amp;ref=25</link>

    <description>02 October</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/631115null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Sanofi-Acquires-Fovea-in-370M-Deal/ArticleStandard/Article/detail/630595?contextCategoryId=48282&amp;ref=25">

    <title>Sanofi Acquires Fovea in 370M Deal</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Sanofi-Acquires-Fovea-in-370M-Deal/ArticleStandard/Article/detail/630595?contextCategoryId=48282&amp;ref=25</link>

    <description>01 October 2009</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630595null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Almac-Plans-500-New-Jobs-for-Northern-Ireland/ArticleStandard/Article/detail/630142?contextCategoryId=48282&amp;ref=25">

    <title>Almac Plans 500 New Jobs for Northern Ireland</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Almac-Plans-500-New-Jobs-for-Northern-Ireland/ArticleStandard/Article/detail/630142?contextCategoryId=48282&amp;ref=25</link>

    <description>30 September 2009</description>

    <dc:date>2009-09-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630142null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Helsinn-and-Eisai-Italy-in-licensing-agreement/ArticleStandard/Article/detail/626804?contextCategoryId=48282&amp;ref=25">

    <title>Helsinn and Eisai Italy in licensing agreement</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Helsinn-and-Eisai-Italy-in-licensing-agreement/ArticleStandard/Article/detail/626804?contextCategoryId=48282&amp;ref=25</link>

    <description>16 September 2009</description>

    <dc:date>2009-09-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626804null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/IMI-Announces-Next-Topics-for-Research/ArticleStandard/Article/detail/626551?contextCategoryId=48282&amp;ref=25">

    <title>IMI Announces Next Topics for Research</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/IMI-Announces-Next-Topics-for-Research/ArticleStandard/Article/detail/626551?contextCategoryId=48282&amp;ref=25</link>

    <description>15 September 2009</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626551null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/AstraZeneca-wins-over-UK-doctors/ArticleStandard/Article/detail/625465?contextCategoryId=48282&amp;ref=25">

    <title>AstraZeneca wins over UK doctors</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/AstraZeneca-wins-over-UK-doctors/ArticleStandard/Article/detail/625465?contextCategoryId=48282&amp;ref=25</link>

    <description>10 September 2009</description>

    <dc:date>2009-09-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625465null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Algeta-amp-Bayer-in-cancer-drug-deal/ArticleStandard/Article/detail/623829?contextCategoryId=48282&amp;ref=25">

    <title>Algeta &amp;amp;amp; Bayer in cancer drug deal</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Algeta-amp-Bayer-in-cancer-drug-deal/ArticleStandard/Article/detail/623829?contextCategoryId=48282&amp;ref=25</link>

    <description>3rd September 2009</description>

    <dc:date>2009-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623829null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Global-Cancer-Cases-to-Grow-by-30-Per-Cent/ArticleStandard/Article/detail/623601?contextCategoryId=48282&amp;ref=25">

    <title>Global Cancer Cases to Grow by 30 Per Cent</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Global-Cancer-Cases-to-Grow-by-30-Per-Cent/ArticleStandard/Article/detail/623601?contextCategoryId=48282&amp;ref=25</link>

    <description>2 September 2009</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623601null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Guiding-Your-Drug-Name-to-Approval/ArticleStandard/Article/detail/617169?contextCategoryId=48282&amp;ref=25">

    <title>Guiding Your Drug Name to Approval</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Guiding-Your-Drug-Name-to-Approval/ArticleStandard/Article/detail/617169?contextCategoryId=48282&amp;ref=25</link>

    <description>06 August 2009</description>

    <dc:date>2009-08-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/322009/617169null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Pfizer-to-develop-clinical-trial-website/ArticleStandard/Article/detail/620739?contextCategoryId=48282&amp;ref=25">

    <title>Pfizer to develop clinical trial website</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Pfizer-to-develop-clinical-trial-website/ArticleStandard/Article/detail/620739?contextCategoryId=48282&amp;ref=25</link>

    <description>21 August 2009</description>

    <dc:date>2009-08-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/342009/620739null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Obama-Advisor-to-Open-Swedish-Life-Sciences-Summit/ArticleStandard/Article/detail/619614?contextCategoryId=48282&amp;ref=25">

    <title>Obama Advisor to Open Swedish Life Sciences Summit</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Obama-Advisor-to-Open-Swedish-Life-Sciences-Summit/ArticleStandard/Article/detail/619614?contextCategoryId=48282&amp;ref=25</link>

    <description>18 August 2009</description>

    <dc:date>2009-08-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/342009/619614null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Is-Tamiflu-Suitable-for-Young-Children/ArticleStandard/Article/detail/617908?contextCategoryId=48282&amp;ref=25">

    <title>Is Tamiflu Suitable for Young Children?</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Is-Tamiflu-Suitable-for-Young-Children/ArticleStandard/Article/detail/617908?contextCategoryId=48282&amp;ref=25</link>

    <description>11 August</description>

    <dc:date>2009-08-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/332009/617908null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-settles-Nigerian-Trovan-case/ArticleStandard/Article/detail/615966?contextCategoryId=48282&amp;ref=25">

    <title>Pfizer settles Nigerian Trovan case</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-settles-Nigerian-Trovan-case/ArticleStandard/Article/detail/615966?contextCategoryId=48282&amp;ref=25</link>

    <description>3 August 2009</description>

    <dc:date>2009-08-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/322009/615966null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/A-busy-time-for-Sanofi/ArticleStandard/Article/detail/615488?contextCategoryId=48282&amp;ref=25">

    <title>A busy time for Sanofi</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/A-busy-time-for-Sanofi/ArticleStandard/Article/detail/615488?contextCategoryId=48282&amp;ref=25</link>

    <description>31 July 2009</description>

    <dc:date>2009-07-31T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/312009/615488null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Flu-Vaccines-Fast-Tracked-in-EU/ArticleStandard/Article/detail/615230?contextCategoryId=48282&amp;ref=25">

    <title>Flu Vaccines Fast-Tracked in EU</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Flu-Vaccines-Fast-Tracked-in-EU/ArticleStandard/Article/detail/615230?contextCategoryId=48282&amp;ref=25</link>

    <description>30 July 2009</description>

    <dc:date>2009-07-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/312009/615230null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/European-Approval-for-Pfizer-Wyeth-Deal/ArticleStandard/Article/detail/612293?contextCategoryId=48282&amp;ref=25">

    <title>European Approval for Pfizer-Wyeth Deal</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/European-Approval-for-Pfizer-Wyeth-Deal/ArticleStandard/Article/detail/612293?contextCategoryId=48282&amp;ref=25</link>

    <description>20 July 2009</description>

    <dc:date>2009-07-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/302009/612293null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/UK-Life-Sciences-Blueprint-Welcomed/ArticleStandard/Article/detail/611708?contextCategoryId=48282&amp;ref=25">

    <title>UK 'Life Sciences Blueprint' Welcomed</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/UK-Life-Sciences-Blueprint-Welcomed/ArticleStandard/Article/detail/611708?contextCategoryId=48282&amp;ref=25</link>

    <description>16 July 2009</description>

    <dc:date>2009-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/292009/611708null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Servier-Singled-Out-for-New-EU-Antitrust-Investiga/ArticleStandard/Article/detail/609542?contextCategoryId=48282&amp;ref=25">

    <title>Servier Singled Out for New EU Antitrust Investigation</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Servier-Singled-Out-for-New-EU-Antitrust-Investiga/ArticleStandard/Article/detail/609542?contextCategoryId=48282&amp;ref=25</link>

    <description>08 July 2009</description>

    <dc:date>2009-07-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/282009/609542null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Merck-signs-discovery-deal-with-Xenon/ArticleStandard/Article/detail/603134?contextCategoryId=48282&amp;ref=25">

    <title>Merck signs discovery deal with Xenon</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Merck-signs-discovery-deal-with-Xenon/ArticleStandard/Article/detail/603134?contextCategoryId=48282&amp;ref=25</link>

    <description>12 June 2009</description>

    <dc:date>2009-06-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603134null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/A-Cautionary-Tale-for-Executives/ArticleStandard/Article/detail/602420?contextCategoryId=48282&amp;ref=25">

    <title>A Cautionary Tale for Executives</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/A-Cautionary-Tale-for-Executives/ArticleStandard/Article/detail/602420?contextCategoryId=48282&amp;ref=25</link>

    <description>9 June 2009</description>

    <dc:date>2009-06-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602420null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-completes-European-debt-offering/ArticleStandard/Article/detail/601617?contextCategoryId=48282&amp;ref=25">

    <title>Pfizer completes European debt offering</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-completes-European-debt-offering/ArticleStandard/Article/detail/601617?contextCategoryId=48282&amp;ref=25</link>

    <description>4 June 2009</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601617null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Pharmaceutical-Execs-Embrace-the-Web/ArticleStandard/Article/detail/601618?contextCategoryId=48282&amp;ref=25">

    <title>Pharmaceutical Execs Embrace the Web</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Pharmaceutical-Execs-Embrace-the-Web/ArticleStandard/Article/detail/601618?contextCategoryId=48282&amp;ref=25</link>

    <description>4 June 2009</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601618null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/IMS-revises-predicted-global-pharma-growth-rate/ArticleStandard/Article/detail/601641?contextCategoryId=48282&amp;ref=25">

    <title>IMS revises predicted global pharma growth rate</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/IMS-revises-predicted-global-pharma-growth-rate/ArticleStandard/Article/detail/601641?contextCategoryId=48282&amp;ref=25</link>

    <description>New prediction reflects incremental pressure from economic crisis.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601641null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/AstraZeneca-and-Merck-form-collaboration/ArticleStandard/Article/detail/600890?contextCategoryId=48282&amp;ref=25">

    <title>AstraZeneca and Merck form collaboration</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/AstraZeneca-and-Merck-form-collaboration/ArticleStandard/Article/detail/600890?contextCategoryId=48282&amp;ref=25</link>

    <description>1 June 2009</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/600890null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe/Elan-in-talks-to-sell-stake-to-Bristol/ArticleStandard/Article/detail/600889?contextCategoryId=48282&amp;ref=25">

    <title>Elan in talks to sell stake to Bristol</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe/Elan-in-talks-to-sell-stake-to-Bristol/ArticleStandard/Article/detail/600889?contextCategoryId=48282&amp;ref=25</link>

    <description>1 June 2009</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/600889null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Novartis-buys-Ebewe-injectables-unit/ArticleStandard/Article/detail/600051?contextCategoryId=48282&amp;ref=25">

    <title>Novartis buys Ebewe injectables unit</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Novartis-buys-Ebewe-injectables-unit/ArticleStandard/Article/detail/600051?contextCategoryId=48282&amp;ref=25</link>

    <description>28 May 2009</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/222009/600051null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/GSK-to-donate-50-million-pandemic-vaccines/ArticleStandard/Article/detail/600050?contextCategoryId=48282&amp;ref=25">

    <title>GSK to donate 50 million pandemic vaccines</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/GSK-to-donate-50-million-pandemic-vaccines/ArticleStandard/Article/detail/600050?contextCategoryId=48282&amp;ref=25</link>

    <description>21 May 2009</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/222009/600050null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/Ranbaxy-chief-steps-down/ArticleStandard/Article/detail/600047?contextCategoryId=48282&amp;ref=25">

    <title>Ranbaxy chief steps down</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/Ranbaxy-chief-steps-down/ArticleStandard/Article/detail/600047?contextCategoryId=48282&amp;ref=25</link>

    <description>1 June 2009</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/222009/600047null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/GW-Pharma-seeks-approval-for-cannabis-based-drug/ArticleStandard/Article/detail/600049?contextCategoryId=48282&amp;ref=25">

    <title>GW Pharma seeks approval for cannabis-based drug</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/GW-Pharma-seeks-approval-for-cannabis-based-drug/ArticleStandard/Article/detail/600049?contextCategoryId=48282&amp;ref=25</link>

    <description>28 May 2009</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/222009/600049null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmexec.findpharma.com/pharmexec/Europe+News/UK-charity-plugs-drug-RampD-gap/ArticleStandard/Article/detail/600052?contextCategoryId=48282&amp;ref=25">

    <title>UK charity plugs drug R&amp;amp;amp;D gap</title>

    <link>
    http://pharmexec.findpharma.com/pharmexec/Europe+News/UK-charity-plugs-drug-RampD-gap/ArticleStandard/Article/detail/600052?contextCategoryId=48282&amp;ref=25</link>

    <description>Cancer Research Technology, a British cancer charity, is to fund clinical trials of a drug owned by
    GlaxoSmithKline (GSK), in a groundbreaking programme to develop promising experimental medicines that are neglected
    due to limited corporate funding.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/222009/600052null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


